Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release

Cancer Research

Volumn 60, Issue 24, 2000, Pages 6950-6957

  Kong, Garheng ^a   Anyarambhatla, Gopal ^a   Petros, William P ^b   Braun, Rod D ^b   Colvin, O Michael ^b   Needham, David ^a   Dewhirst, Mark W ^b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; DRUG CARRIER; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG RELEASE; DRUG TUMOR LEVEL; ENCAPSULATION; FLUORESCENCE; HYPERTHERMIA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TEMPERATURE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEVER; HEAT; HUMANS; LIPOSOMES; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RANDOM ALLOCATION; TEMPERATURE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034671219     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Barriers to drug delivery in solid tumors
2. Drug resistance and experimental chemotherapy
3. Transvascular drug delivery in solid tumors
4. Cancer therapy with liposomal formulations of anticancer drugs
5. Liposomes: Opportunities in drug delivery
6. Liposomes containing synthetic derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
7. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue
8. A Phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas
9. Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy
10. Enhanced anticancer therapy mediated by specialized liposomes
11. Hyperthermia and liposomes
12. Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors
13. Can mild hyperthermia improve tumour oxygenation?
14. Enhanced delivery of a monoclonal antibody F(ab×)2 fragment to subcutaneous human glioma xenografts using local hyperthermia
15. Effect of hyperthermia on tumor uptake of radiolabeled anti-neural cell adhesion molecule antibody in small-cell lung cancer xenografts
16. Hyperthermic modulation of radiolabelled antibody uptake in a human glioma xenograft and normal tissues
17. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumour interstitial fluid pressure
18. Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability
19. The effects of hyperthermia on vascular permeability in experimental liver metastasis
20. Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks
21. Temperature-dependent drug release from large unilamellar liposomes
22. In vitro evaluation of the association of thermosensitive liposome-encapsulated doxorubicin with hyperthermia
23. Enhancement of the phase transition permeability of DPPC liposomes by incorporation of MPPC: A new temperature-sensitive liposome for use with mild hyperthermia
24. Thermochemotherapy: Synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation
25. Temperature dependence of Adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1, 3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro
26. Clinical hyperthermia and chemotherapy
27. Whole body hyperthermia and intraperitoneal carboplatin in residual ovarian cancer
28. Systemic hyperthermia and ICE chemotherapy for sarcoma patients: Rationale and clinical status
29. Hyperthermic treatment of malignant diseases: Current status and a view toward the future
30. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia
31. Liposomes and hyperthermia in mice: Increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes
32. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia
33. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin
34. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy
35. Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor
36. Thermosensitive sterically stabilized liposomes: Formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma
37. A new temperature sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model
38. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential
39. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential
40. Studies on the in vivo disposition of Adriamycin in human tumours which exhibit different responses to the drug
41. Method for determination of 4′-deoxydoxorubicin, 4′-deoxydoxorubicinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography
42. Plasma pharmacokinetics of Adriamycin and Adriamycinol: Implications for the design of in vitro experiments and treatment protocols
43. Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate
44. Selective delivery of liposome-associated cis-dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth
45. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia
46. Enhancement of doxorubicin-induced cytotoxicity by hyperthermia in ehrlich ascites cells
47. Direct measurement of doxorubicin concentration in the intact, living single cancer cell during hyperthermia
48. Tumor eradication and cell survival after localized hyperthermia induced by ultrasound
49. Effect of hyperthermia on the in vitro metabolism of doxorubicin
50. Interaction between Adriamycin cytotoxicity and hyperthermia: Growth-phase-dependent thermal sensitization
51. An update on the anticancer effects of a combination of chemotherapy and hyperthermia
52. Pharmacokinetics of anthracyclines
53. Effects of heat on blood flow
54. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size
55. Improved antitumor activity of cis-bis-neodecanoato-trans-R, R-1, 2- diaminocyclohexaneplatinum(II) entrapped in long-circulating liposomes
56. Blood flow in human tumors during local hyperthermia
57. Effect of hyperthermia on vascular function in normal and neoplastic tissues
58. Effect of hyperthermia on microvascular permeability to macromolecules in normal and tumor tissues
59. Lipid phase transitions and phase diagrams. I. Lipid phase transitions
60. Permeability of lipid bilayers near the phase transition
61. Thermal Dosimetry
62. A Critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
63. A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model